Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC)

Historical Holders from Q2 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
TDOC on NYSE
Shares outstanding
175,611,455
Price per share
$7.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
123,251,969
Total reported value
$953,036,516
% of total 13F portfolios
0%
Share change
-4,509,266
Value change
-$43,926,987
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
344
Price from insider filings
$7.14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $183,075,446 21,018,995 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 7.8% $99,368,053 13,556,351 BlackRock, Inc. 31 Mar 2025
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025
As of 30 Sep 2025, Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 344 institutional shareholders filing 13F forms. They hold 123,251,969 shares. of 175,611,455 outstanding shares (70%) .

Top 25 institutional shareholders own 54% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 21,910,950 +4.2% 0% $169,371,644
BlackRock, Inc. 7.9% 13,878,254 +0.31% 0% $107,278,903
RENAISSANCE TECHNOLOGIES LLC 4.7% 8,176,842 +12% 0.08% $63,206,989
DIMENSIONAL FUND ADVISORS LP 3.9% 6,889,194 +24% 0.01% $53,260,110
Point72 Asset Management, L.P. 3.3% 5,763,342 -26% 0.1% $44,550,635
STATE STREET CORP 2.7% 4,659,892 -6.4% 0% $36,020,965
GEODE CAPITAL MANAGEMENT, LLC 2.4% 4,169,919 +0.48% 0% $32,238,443
MORGAN STANLEY 2.1% 3,600,271 +84% 0% $27,830,104
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 2,542,051 -3.8% 0% $19,650,054
GOLDMAN SACHS GROUP INC 1.4% 2,522,994 -3% 0% $19,502,744
AMERIPRISE FINANCIAL INC 1.3% 2,284,697 +11% 0% $17,660,705
Nuveen, LLC 1.1% 1,917,422 +58% 0% $14,821,672
NORTHERN TRUST CORP 1% 1,817,911 +0.04% 0% $14,052,452
Allianz Asset Management GmbH 0.92% 1,619,391 +189% 0.02% $12,517,892
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.86% 1,511,111 -26% 0.02% $11,680,888
TWO SIGMA ADVISERS, LP 0.82% 1,439,617 -49% 0.02% $11,128,239
TANG CAPITAL MANAGEMENT LLC 0.8% 1,400,000 0% 0.42% $10,822,000
Invenomic Capital Management LP 0.78% 1,372,977 -5.1% 0.56% $10,613,112
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.71% 1,251,776 +25% 0.21% $9,676,228
CITADEL ADVISORS LLC 0.69% 1,218,205 +33% 0.01% $9,416,725
UBS Group AG 0.68% 1,201,784 +20% 0% $9,289,791
TWO SIGMA INVESTMENTS, LP 0.64% 1,131,668 -48% 0.01% $8,747,794
Quantinno Capital Management LP 0.63% 1,111,957 +86% 0.02% $8,595,434
JANE STREET GROUP, LLC 0.62% 1,081,326 +382% 0.01% $8,358,650
JUPITER ASSET MANAGEMENT LTD 0.56% 980,068 0.07% $7,575,926

Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 1,350,350 $9,470,981 +$7,059,601 700% 11
2025 Q3 123,251,969 $953,036,516 -$43,926,987 773% 344
2025 Q2 127,657,050 $1,111,810,150 +$28,908,039 871% 348
2025 Q1 124,764,453 $993,137,558 -$13,210,237 796% 368
2024 Q4 126,600,183 $1,150,909,215 +$5,732,507 909% 366
2024 Q3 125,343,265 $1,150,235,748 -$100,725,771 918% 352
2024 Q2 138,653,865 $1,356,107,775 +$78,896,049 978% 389
2024 Q1 129,813,184 $1,959,292,768 +$8,558,227 1,510% 411
2023 Q4 128,213,716 $2,762,470,436 +$64,064,682 2,155% 425
2023 Q3 124,707,305 $2,318,095,592 -$112,449,287 1,859% 418
2023 Q2 128,734,634 $3,259,624,540 -$197,804,335 2,532% 418
2023 Q1 136,344,301 $3,528,176,976 +$69,660,076 2,590% 416
2022 Q4 134,795,560 $3,187,915,143 -$88,463,415 2,365% 419
2022 Q3 137,929,338 $3,500,590,930 -$132,587,746 2,535.01% 421
2022 Q2 142,508,101 $4,752,897,156 -$35,457,280 3,321% 492
2022 Q1 135,294,586 $9,760,150,727 -$44,236,110 7,213% 640
2021 Q4 135,661,577 $12,464,617,010 -$96,730,604 9,182% 689
2021 Q3 133,460,521 $16,925,944,366 +$674,213,489 12,680.97% 738
2021 Q2 127,751,069 $21,259,926,344 +$1,036,756,412 16,628.99% 807
2021 Q1 121,322,454 $22,048,095,012 +$973,044,719 18,175% 873
2020 Q4 109,175,126 $21,828,607,477 +$6,575,258,095 19,996.08% 869
2020 Q3 75,563,046 $16,555,972,646 +$917,790,340 21,923.99% 730
2020 Q2 71,460,376 $13,644,498,539 -$180,652,715 19,083.92% 654
2020 Q1 72,838,954 $11,295,952,445 -$2,132,897,022 15,501.01% 559
2019 Q4 87,035,459 $7,286,337,875 -$311,263,665 8,371.98% 404
2019 Q3 90,856,564 $6,151,556,774 +$311,350,683 6,772.01% 365
2019 Q2 86,279,161 $5,708,002,798 +$184,430,573 6,640.96% 360
2019 Q1 84,967,430 $4,724,239,062 +$201,451,274 5,559.98% 355
2018 Q4 81,502,841 $4,039,756,305 +$65,534,475 4,956.99% 321
2018 Q3 78,683,955 $6,793,917,690 +$279,097,203 8,634.99% 330
2018 Q2 76,024,459 $4,413,324,206 -$62,794,723 5,804.98% 272
2018 Q1 77,172,756 $3,107,046,518 +$70,245,035 4,030% 229
2017 Q4 75,618,965 $2,635,297,138 +$300,630,734 3,485% 204
2017 Q3 65,338,332 $2,166,327,928 +$268,095,591 3,315.01% 177
2017 Q2 57,326,616 $1,989,441,272 +$288,789,640 3,470% 165
2017 Q1 50,788,462 $1,269,721,925 +$612,842,037 2,500% 131
2016 Q4 28,818,430 $475,514,658 +$62,340,869 1,650% 107
2016 Q3 24,591,861 $450,136,800 +$92,859,707 1,830.97% 101
2016 Q2 18,488,436 $296,177,335 +$63,261,690 1,601.94% 85
2016 Q1 15,770,964 $151,754,000 -$36,741,446 959.99% 78
2015 Q4 18,650,348 $334,951,386 -$60,380,110 1,796% 73
2015 Q3 20,870,768 $457,767,253 +$452,106,452 2,228.97% 88
2015 Q2 266,265 $5,009,000 +$5,009,000 1,900% 14